- ISIN
- US4626292050
- Sector
- Healthcare
Highlights
- Market Cap
- $14.20B
- Enterprise Value
- $13.87B
- EPS (TTM)
- $2.38
- PE Ratio
- 18.15
- Total Revenue (TTM)
- $7.35B
- Gross Profit (TTM)
- $5.86B
- EBITDA (TTM)
- $2.22B
- Year Range
- $28.66 - $51.10
- ROA (TTM)
- 11.37%
- ROE (TTM)
- 18.20%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IPSEY Performance Chart
Ipsen SA ADR (IPSEY) is up 18.8% since the beginning of the year. At $43 per share, IPSEY is trading 15.5% below its 52-week high of $51. Investors who bought $1,000 worth of IPSEY shares 5 years ago would now be looking at an investment worth $1,753.
Loading charts...
Returns By Period
Ipsen SA ADR (IPSEY) has returned 18.82% so far this year and 46.66% over the past 12 months. Over the last ten years, IPSEY has returned 11.78% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Ipsen SA ADR
- 1D
- -2.82%
- 1M
- -11.98%
- YTD
- 18.82%
- 6M
- 19.91%
- 1Y
- 46.66%
- 3Y*
- 14.23%
- 5Y*
- 11.88%
- 10Y*
- 11.78%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
IPSEY Monthly Returns History
Based on dividend-adjusted daily data since Aug 6, 2010, IPSEY's average daily return is +0.07%, while the average monthly return is +1.29%. At this rate, an investment would double in approximately 4.5 years.
Historically, 51% of months were positive and 49% were negative. The best month was Apr 2020 with a return of +40.9%, while the worst month was Apr 2012 at -29.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.
On a daily basis, IPSEY closed higher 35% of trading days. The best single day was Mar 20, 2020 with a return of +19.7%, while the worst single day was Apr 10, 2012 at -25.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 12.10% | 17.30% | -3.16% | 6.02% | -8.49% | -3.82% | 18.82% | ||||||
| 2025 | 6.08% | -6.02% | 1.19% | -3.50% | 4.96% | 3.22% | 6.87% | 5.62% | -2.44% | 6.08% | 4.26% | -0.98% | 27.18% |
| 2024 | -1.31% | -4.24% | 7.25% | 0.60% | 9.46% | -7.41% | -6.08% | 5.49% | 3.51% | -1.84% | -6.09% | 1.61% | -0.74% |
| 2023 | -2.94% | 10.16% | -4.31% | 10.00% | -3.97% | 6.56% | 2.70% | 1.63% | 2.19% | -9.03% | -5.69% | 5.21% | 10.87% |
| 2022 | 3.54% | 22.84% | 2.55% | -16.15% | -2.81% | -6.70% | 11.83% | -6.34% | -3.90% | 10.85% | 9.79% | -4.55% | 15.94% |
| 2021 | 10.59% | -4.72% | 0.93% | 12.87% | 7.01% | 1.70% | 1.88% | -6.40% | -3.57% | 5.84% | -5.87% | -2.45% | 16.76% |
Benchmark Metrics
Ipsen SA ADR has an annualized alpha of 15.24%, beta of 0.21, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since August 09, 2010.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (68.42%) than losses (58.69%) - typical of diversified or defensive assets.
- Beta of 0.21 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 15.24%
- Beta
- 0.21
- R²
- 0.01
- Upside Capture
- 68.42%
- Downside Capture
- 58.69%
Return for Risk
Risk / Return Rank
IPSEY ranks 84 for risk / return — in the top 84% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Ipsen SA ADR (IPSEY) and compare them to S&P 500 Index.
| IPSEY | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.60 | 2.39 | -0.79 |
Sortino ratioReturn per unit of downside risk | 2.43 | 3.25 | -0.82 |
Omega ratioGain probability vs. loss probability | 1.41 | 1.43 | -0.03 |
Calmar ratioReturn relative to maximum drawdown | 3.17 | 3.11 | +0.06 |
Martin ratioReturn relative to average drawdown | 10.91 | 14.38 | -3.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Ipsen SA ADR provided a 0.92% dividend yield over the last twelve months, with an annual payout of $0.40 per share. The company has been increasing its dividends for 5 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.40 | $0.40 | $0.33 | $0.32 | $0.32 | $0.28 | $0.27 | $0.28 | $0.31 | $0.23 | $0.47 | $0.23 |
Dividend yield | 0.92% | 1.10% | 1.13% | 1.10% | 1.17% | 1.17% | 1.33% | 1.27% | 0.96% | 0.77% | 2.60% | 1.37% |
Monthly Dividends
The table displays the monthly dividend distributions for Ipsen SA ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 |
Dividend Yield & Payout
Dividend Yield
Ipsen SA ADR has a dividend yield of 0.92%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Ipsen SA ADR has a payout ratio of 28.29%, which is quite average when compared to the overall market. This suggests that Ipsen SA ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Ipsen SA ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ipsen SA ADR was 77.92%, occurring on Mar 19, 2020. Recovery took 1472 trading sessions.
The current Ipsen SA ADR drawdown is 14.80%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -77.92%Mar 2020 | 1y 6mo | 5y 10mo | 7y 4moSep 2018 - Jan 2026 |
2012 bear market2012 | -40.68%Jul 2012 | 3mo 1d | 8mo 8d | 11mo 9dApr 2012 - Mar 2013 |
2016 bear market2016 | -25.39%Mar 2016 | 5mo 29d | 6mo 17d | 1y 11dSep 2015 - Sep 2016 |
2017 correction2017 | -19.45%Dec 2017 | 2mo 16d | 1mo 17d | 4mo 3dSep 2017 - Jan 2018 |
2014 correction2014 | -16.96%Apr 2014 | 3mo 9d | 1mo 17d | 4mo 26dJan 2014 - May 2014 |
Drawdown Indicators
| IPSEY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.92% | -56.78% | -21.14% |
Max Drawdown (1Y)Largest decline over 1 year | -14.80% | -9.10% | -5.70% |
Max Drawdown (3Y)Largest decline over 3 years | -24.19% | -18.90% | -5.29% |
Max Drawdown (5Y)Largest decline over 5 years | -33.95% | -25.43% | -8.52% |
Max Drawdown (10Y)Largest decline over 10 years | -77.92% | -33.92% | -44.00% |
Current DrawdownCurrent decline from peak | -14.80% | 0.00% | -14.80% |
Average DrawdownAverage peak-to-trough decline | -19.90% | -10.72% | -9.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.29% | 1.97% | +2.32% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Ipsen SA ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Ipsen SA ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for IPSEY, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IPSEY has a P/E ratio of 18.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IPSEY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IPSEY has a P/S ratio of 1.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IPSEY in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IPSEY has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with IPSEY
Add Ipsen SA ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IPSEY